Inogen Inc (INGN)
6.90
+0.20
(+2.99%)
USD |
NASDAQ |
Apr 23, 16:00
6.895
0.00 (0.00%)
After-Hours: 20:00
Inogen Cash from Financing (Quarterly): -0.014M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.014M |
| September 30, 2023 | 0.448M |
| June 30, 2023 | -0.033M |
| March 31, 2023 | 0.559M |
| December 31, 2022 | -0.112M |
| September 30, 2022 | 0.701M |
| June 30, 2022 | -0.101M |
| March 31, 2022 | -0.108M |
| December 31, 2021 | -0.03M |
| September 30, 2021 | 4.69M |
| June 30, 2021 | 5.913M |
| March 31, 2021 | 4.427M |
| December 31, 2020 | 0.084M |
| September 30, 2020 | 0.946M |
| June 30, 2020 | 0.061M |
| March 31, 2020 | 0.975M |
| December 31, 2019 | 0.982M |
| September 30, 2019 | 1.329M |
| June 30, 2019 | 0.172M |
| March 31, 2019 | 2.446M |
| December 31, 2018 | 6.087M |
| September 30, 2018 | 5.006M |
| Date | Value |
|---|---|
| June 30, 2018 | 2.058M |
| March 31, 2018 | 5.145M |
| December 31, 2017 | 3.282M |
| September 30, 2017 | 3.411M |
| June 30, 2017 | 4.508M |
| March 31, 2017 | 2.803M |
| December 31, 2016 | 2.294M |
| September 30, 2016 | 3.084M |
| June 30, 2016 | 1.821M |
| March 31, 2016 | 0.515M |
| December 31, 2015 | -1.098M |
| September 30, 2015 | -1.767M |
| June 30, 2015 | 1.001M |
| March 31, 2015 | 2.245M |
| December 31, 2014 | 1.225M |
| September 30, 2014 | -12.25M |
| June 30, 2014 | 4.313M |
| March 31, 2014 | 50.59M |
| December 31, 2013 | -1.882M |
| September 30, 2013 | 3.674M |
| June 30, 2013 | 1.397M |
| March 31, 2013 | -0.105M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.112M
Minimum
Dec 2022
5.913M
Maximum
Jun 2021
1.099M
Average
0.448M
Median
Sep 2023
Cash from Financing (Quarterly) Benchmarks
| Oragenics Inc | -0.1806M |
| Palatin Technologies Inc | 4.974M |
| Oramed Pharmaceuticals Inc | -25.00M |
| vTv Therapeutics Inc | -0.282M |
| G1 Therapeutics Inc | 0.034M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.148M |
| Cash from Investing (Quarterly) | 4.128M |
| Free Cash Flow | -30.24M |
| Free Cash Flow Per Share (Quarterly) | -0.4053 |
| Free Cash Flow to Equity (Quarterly) | -9.45M |
| Free Cash Flow to Firm (Quarterly) | -9.45M |
| Free Cash Flow Yield | -18.93% |